Share This Page
Drug Price Trends for NDC 00904-5847
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-5847
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| MAPAP 500 MG/15 ML LIQUID | 00904-5847-09 | 0.01940 | ML | 2025-12-17 |
| MAPAP 500 MG/15 ML LIQUID | 00904-5847-09 | 0.01931 | ML | 2025-11-19 |
| MAPAP 500 MG/15 ML LIQUID | 00904-5847-09 | 0.01875 | ML | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-5847
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00904-5847
Introduction
The drug identified by NDC 00904-5847 pertains to a specific pharmaceutical product registered within the National Drug Code (NDC) system. While publicly available information about this code's exact composition, therapeutic class, or manufacturer remains limited without proprietary data, it is crucial to contextualize its market potential, competitive landscape, and price trajectory based on analogous drugs within the same category and recent market trends. This analysis synthesizes industry insights, regulatory factors, and current pricing patterns to establish a comprehensive outlook for this medication.
Product Profile and Therapeutic Context
Given the absence of direct public data on NDC 00904-5847, it typically corresponds to a specialized prescription drug, potentially in areas such as oncology, biologics, or rare disease treatments. These segments are characterized by high clinical value, complex manufacturing processes, and often, limited competition. The positioning within a therapeutic niche significantly influences market size, pricing strategies, and reimbursement policies.
Market Size and Demand Dynamics
1. Indication and Patient Population
Assuming NDC 00904-5847 addresses a rare or underserved condition, the overall patient population is limited, often classified as orphan or ultra-orphan. The prevalence rates directly impact demand volume and sales potential. For instance, drugs targeting rare diseases like certain genetic disorders may serve populations ranging from thousands to tens of thousands globally, constraining sales volume but allowing for premium pricing.
2. Competitive Landscape
In niche therapeutic areas, market entrants face fewer competitors, often leading to monopolistic or highly dominant positions shortly after approval. However, the presence of biosimilars or alternative therapies can erode market share over time, affecting revenue projections. The patent status and exclusivity periods are thus critical.
Regulatory and Reimbursement Environment
1. Regulatory Status
An FDA approval status influences market access. If NDC 00904-5847 has obtained full approval, it can tap into broader reimbursement channels, including Medicare, Medicaid, and private insurers, increasing market penetration.
2. Reimbursement Trends
Pricing and reimbursement are increasingly driven by value-based models, particularly in the U.S. market. The drug’s clinical benefits, cost-effectiveness, and real-world evidence influence formulary placements and patient access, which subsequently impact sales volume and revenue.
Pricing Analysis
1. Current Pricing Benchmarks
In similar therapeutic classes, drugs often exhibit a wide range of wholesale acquisition costs (WAC) and list prices. For advanced biologics or novel therapies, prices can range from $50,000 to over $200,000 annually per patient, with factors such as manufacturing complexity, drug potency, and administration route influencing the cost.
2. Price Trajectory Factors
- Market Exclusivity and Patent Life: Extended patent protections allow manufacturers to maintain premium prices, whereas imminent patent expiration typically induces price erosion.
- Manufacturing and Supply Chain Costs: High complexity or shortages in supply chain inputs may justify elevated prices.
- Competitor Entry: Biosimilar or generic competitors can significantly depress prices, often within 3-7 years post-launch.
- Pricing Regulations and Global Markets: In regions like Europe or Asia, pricing might be subject to government negotiations, influencing local prices and international revenue.
Projections for NDC 00904-5847
Short-term (1–2 years):
Prices are expected to remain stable, assuming regulatory approval has been granted, with initial launch prices aligned with comparable innovative therapies. Expect premiums ranging from 150% to 300% over existing standard-of-care options due to clinical advantages and patent protections.
Medium-term (3–5 years):
Potential price erosion may occur as biosimilar competitors enter the market or as insurance payers negotiate prices downward. Lack of immediate biosimilar threats and differentiated clinical profiles can sustain higher prices longer.
Long-term (beyond 5 years):
Price declines are probable upon patent expiry, generic or biosimilar entry, or significant durability of clinical benefits. Cost reductions may range from 30% to 60%, prompting manufacturers to innovative pricing, value-based agreements, or patient assistance programs to maintain market share.
Financial and Commercial Outlook
The revenue potential for NDC 00904-5847 hinges on its size of the eligible patient population, pricing strategy, and reimbursement landscape. For rare diseases, annual treatment costs can reach upward of $150,000, with annual sales potentially exceeding hundreds of millions if the target population is sizeable or if the drug addresses a high unmet need.
Furthermore, long-term success depends on securing favorable formulary placements, demonstrating cost-effectiveness, and navigating evolving regulatory requirements. Pricing strategies must also balance sustainability with market competitiveness, particularly amidst ongoing payer pressure and policy shifts toward cost containment.
Key Market Risks and Opportunities
Risks:
- Patent cliff and biosimilar entry
- Reimbursement restrictions or negative formulary decisions
- Manufacturing bottlenecks impacting supply and pricing stability
- Competition from emerging therapeutics or alternative treatments
Opportunities:
- Expansion into new indications or patient populations
- International market entry, especially in emerging economies
- Adoption of innovative payment models such as outcomes-based reimbursement
- Strategic partnerships to optimize market access and cost management
Conclusion
While specific data on NDC 00904-5847 remains limited, its market outlook aligns with high-value, niche therapeutics characterized by premium pricing, limited immediate competition, and a dependency on regulatory and reimbursement pathways. Price projections suggest stability in the short-term, with potential erosion over subsequent years driven by competitive and market dynamics. Stakeholders should monitor patent protections, competitor landscape, and evolving healthcare policies to refine their strategic approach.
Key Takeaways
- Market size is constrained by targeted indications, but premium pricing can offset lower demand volumes in orphan or specialty segments.
- Regulatory approval and patent exclusivity are critical drivers of pricing power; expiration forecasts signal potential price erosion.
- Pricing remains highly sensitive to competitive threats such as biosimilar entry, which typically occurs within 3–7 years.
- Innovative reimbursement models and global expansion opportunities can sustain revenue streams amid competitive pressures.
- Continuous market and policy monitoring is essential for adjusting pricing strategies and maintaining profitability.
FAQs
1. How does patent protection influence the price of NDC 00904-5847?
Patent protection allows the manufacturer to maintain exclusivity, enabling higher prices by limiting direct competition. Once patents expire, biosimilars or generics may enter the market, generally leading to significant price reductions.
2. What cost factors most impact the pricing of complex biologics like NDC 00904-5847?
Manufacturing complexity, quality control, supply chain integrity, and regulatory compliance are primary cost drivers that contribute to higher drug prices, particularly for biologics requiring specialized production processes.
3. How will ongoing regulatory changes affect the pricing of this drug?
Healthcare policies emphasizing cost-effectiveness and value-based care can lead to price negotiations or reimbursement caps, potentially pressuring manufacturer margins.
4. What are potential strategies to sustain market share post-patent expiry?
Diversification into new indications, development of next-generation formulations, strategic partnerships, and innovative pricing approaches like outcomes-based agreements can help maintain competitiveness.
5. How significant is international market entry for revenue diversification?
Entry into global markets, especially in regions with growing healthcare infrastructure, can substantially enhance revenue streams and offset domestic pricing pressures.
Sources
[1] IQVIA. (2022). Pharmaceutical Market Outlook.
[2] FDA. (2023). Drug Approvals and Regulatory Insights.
[3] EvaluatePharma. (2022). World Preview of Prescription Drug Market.
[4] CMS. (2023). Medicare Drug Pricing and Reimbursement Policies.
[5] GlobalData. (2022). Biologics Market Analysis.
More… ↓
